Structure Database (LMSD)
| LM_ID | Common Name | Systematic Name | Main Class | Sub Class | Mass | Formula |
|---|---|---|---|---|---|---|
| LMFA01170034 | 5Z,8Z,11Z,14Z-Eicosatetraenedioic acid | 5Z,8Z,11Z,14Z-Eicosatetraenedioic acid | Fatty Acids and Conjugates [FA01] | Dicarboxylic acids [FA0117] | 334.21 | C20H30O4 |
| LMFA03010033 | 13,14-dihydro-15-keto-PGA2 | 9,15-dioxo-5Z,10-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010051 | 15-deoxy-delta-12,14-PGD2 | 9S-hydroxy-11-oxo-5Z,12E,14E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010092 | 15R-PGA2 | 9oxo-15R-hydroxy-5Z,10Z,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010235 | 5E-PGB2 | 15S-hydroxy-9-oxo-5E,8(12),13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010100 | 5-trans-PGA2 | 9oxo-15S-hydroxy-5E,10Z,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010034 | bicyclo-PGE2 | 9,15-dioxo-5Z-prostaenoic acid-cyclo[11S,16] | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010020 | delta-12-PGJ2 | 11-oxo-15S-hydroxy-5Z,9Z,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010035 | PGA2 | 9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010018 | PGB2 | 15S-hydroxy-9-oxo-5Z,8(12),13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010133 | PGC2 | 9-oxo-15S-hydroxy-5Z,11Z,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010198 | PGE2 1,15-lactone | 9-oxo-11R-hydroxy-5Z,13E-prostadienoic acid-1,15S-lactone | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010197 | PGF3alpha-1,15-lactone | 9S,11R-dihydroxy-5Z,13E,17Z-prostatrienoic acid-1,15S-lactone | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03010019 | PGJ2 | 11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 334.21 | C20H30O4 |
| LMFA03020024 | 12-oxo-LTB4 | 5S-hydroxy-12-keto-6Z,8E,10E,14Z-eicosatetraenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 334.21 | C20H30O4 |
| LMFA03020017 | 14,15-dehydro-LTB4 | 5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 334.21 | C20H30O4 |
| LMFA03020069 | 5-Oxo-6-trans-leukotriene B4 | (6E,8E,10E,12R,14Z)-12-hydroxy-5-oxoicosa-6,8,10,14-tetraenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 334.21 | C20H30O4 |
| LMFA03020010 | LTB5 | 5S,12S-dihydroxy-6Z,8E,14Z,17Z-eicosapentanenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 334.21 | C20H30O4 |
| LMFA03060117 | 14,15-epoxy,13-HETE | 14,15-epoxy-13-hydroxy-5Z,8Z,11Z,17Z-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 334.21 | C20H30O4 |
| LMFA03060115 | 14,15-epoxy,16-HETE | 14,15-epoxy-16-hydroxy-5Z,8Z,11Z,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 334.21 | C20H30O4 |
| LMFA03060075 | 5,6-Ep-15S-HETE | 5S,6S-epoxy-15S-hydroxy-7E,9E,11Z,13E-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 334.21 | C20H30O4 |
| LMFA03060116 | 8,9-epoxy,7-HETE | 8,9-epoxy-7-hydroxy-5Z,11Z,14Z,17Z-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 334.21 | C20H30O4 |
| LMFA03070050 | 11,18-di-HEPE | 11,18-dihydroxy-5Z,8Z,12E,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070051 | 12,18-di-HEPE | 12,18-dihydroxy-5Z,8Z,10E,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070012 | 12S-HpEPE | 12S-hydroperoxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070056 | 14-HpEPE | 14-hydroperoxy-5Z,8Z,11Z,15E,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070013 | 15S-HpEPE | 15S-hydroperoxy-5Z,8Z,11Z,13E,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070043 | 18R-HpEPE | 18R-hydroperoxy-5Z,8Z,11Z,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070059 | 5R-HpEPE | 5R-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070001 | 5S-HpEPE | 5S-hydroperoxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070052 | 8,18-di-HEPE | 8,18-dihydroxy-5Z,9E,11Z,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070061 | 9,15-diHEPE | 9S,15S-dihydroxy-5Z,7E,11Z,13E,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070057 | 9S-HpEPE | 9S-hydroperoxy-5Z,7E,11Z,14Z,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03070060 | - | 12R,13R-dihydroxy-eicosa-5Z,8Z,10E,14Z,17Z-pentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 334.21 | C20H30O4 |
| LMFA03110263 | 11-epi-8-A2-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110282 | 11-epi-8-J2-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,5S)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110248 | 12-A2-IsoP | 4-((1R,2R)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110247 | 12-epi-12-A2-IsoP | 4-((1R,2R)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110088 | 12-epi-12-J2-IsoP | 12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5S,9S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110087 | 12-J2-IsoP | 12S-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5S,9S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110138 | 15-A2-IsoP | 9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8R,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110139 | 15-epi-15-A2-IsoP | 9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8R,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110102 | 15-epi-15-J2-IsoP | 15R-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110101 | 15-J2-IsoP | 15S-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110249 | 5,12-diepi-12-A2-IsoP | 4-((1S,2R)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110275 | 5,12-diepi-12-J2-IsoP | 4-((1R,5S)-5-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110255 | 5,8-diepi-5-A2-IsoP | (R,E)-5-hydroxy-7-((1S,2R)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110279 | 5,8-diepi-5-J2-IsoP | (R,E)-5-hydroxy-7-((S,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110257 | 5-A2-IsoP | (S,E)-5-hydroxy-7-((1R,2R)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110250 | 5-epi-12-A2-IsoP | 4-((1S,2R)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110274 | 5-epi-12-J2-IsoP | 4-((1R,5S)-5-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110256 | 5-epi-5-A2-IsoP | (R,E)-5-hydroxy-7-((1R,2R)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110073 | 5-epi-5-J2-IsoP | 5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110072 | 5-J2-IsoP | 5S-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110264 | 8,11-diepi-8-A2-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110283 | 8,11-diepi-8-J2-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,5S)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110142 | 8,15-diepi-15-A2-IsoP | 9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110135 | 8,15-diepi-15-J2c-IsoP | 11-oxo-15R-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110133 | 8,15-diepi-15-J2t-IsoP | 11-oxo-15R-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110266 | 8-A2-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110141 | 8-epi-15-A2-IsoP | 9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110114 | 8-epi-15-J2-IsoP | 11-oxo-15S-hydroxy-5Z,9,13E-prostatrienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110258 | 8-epi-5-A2-IsoP | 5S-hydroxy-9-oxo-6E,10,14Z-prostatrienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110278 | 8-epi-5-J2-IsoP | (S,E)-5-hydroxy-7-((S,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110265 | 8-epi-8-A2-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110060 | 8-epi-8-J2-IsoP | 8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11R,15S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110059 | 8-J2-IsoP | 8S-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11R,15S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110267 | ent-11-epi-8-A2-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110280 | ent-11-epi-8-J2-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,5R)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110252 | ent-12-A2-IsoP | 4-((1S,2S)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110251 | ent-12-epi-12-A2-IsoP | 4-((1S,2S)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110089 | ent-12-epi-12-J2-IsoP | 12S-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110086 | ent-12-J2-IsoP | 12R-hydroxy-8-oxo-6,10E,14Z-prostatrienoic acid-cyclo[5R,9R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110137 | ent-15-A2-IsoP | 9-oxo-15R-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110140 | ent-15-epi-15-A2-IsoP | 9-oxo-15S-hydroxy-5Z,10,13E-prostatrienoic acid-cyclo[8S,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110103 | ent-15-epi-15-J2-IsoP | 15S-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8R,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110100 | ent-15-J2-IsoP | 15R-hydroxy-11-oxo-5Z,9,13E-prostatrienoic acid-cyclo[8R,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110253 | ent-5,12-diepi-12-A2-IsoP | 4-((1R,2S)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110273 | ent-5,12-diepi-12-J2-IsoP | 4-((1S,5R)-5-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110259 | ent-5,8-diepi-5-A2-IsoP | (S,E)-5-hydroxy-7-((1R,2S)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110277 | ent-5,8-diepi-5-J2-IsoP | (S,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110261 | ent-5-A2-IsoP | (R,E)-5-hydroxy-7-((1S,2S)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110254 | ent-5-epi-12-A2-IsoP | 4-((1R,2S)-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110272 | ent-5-epi-12-J2-IsoP | 4-((1S,5R)-5-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)butanoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110260 | ent-5-epi-5-A2-IsoP | (S,E)-5-hydroxy-7-((1S,2S)-2-((Z)-oct-2-en-1-yl)-5-oxocyclopent-3-en-1-yl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110074 | ent-5-epi-5-J2-IsoP | 5S-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110071 | ent-5-J2-IsoP | 5R-hydroxy-11-oxo-6E,14Z,12-prostatrienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110268 | ent-8,11-diepi-8-A2-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110281 | ent-8,11-diepi-8-J2-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,5R)-4-oxo-5-pentylcyclopent-2-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110270 | ent-8-A2-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110262 | ent-8-epi-5-A2-IsoP | 5S-hydroxy-9-oxo-6E,10,14Z-prostatrienoic acid-cyclo[8R,12S] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110276 | ent-8-epi-5-J2-IsoP | (R,E)-5-hydroxy-7-((R,E)-2-((Z)-oct-2-en-1-ylidene)-3-oxocyclopentyl)hept-6-enoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110269 | ent-8-epi-8-A2-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,5S)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110061 | ent-8-epi-8-J2-IsoP | 8S-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03110058 | ent-8-J2-IsoP | 8R-hydroxy-14-oxo-5Z,9E,12-prostatrienoic acid-cyclo[11S,15R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 334.21 | C20H30O4 |
| LMFA03140006 | 18R-Resolvin E3 | 17R,18R-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid | Eicosanoids [FA03] | - | 334.21 | C20H30O4 |
| LMFA03140004 | 18S-Resolvin E2 | 5S,18S-dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | - | 334.21 | C20H30O4 |
| LMFA03140007 | 18S-Resolvin E3 | 17R,18S-dihydroxy-5Z,8Z,11Z,13E,15E-eicosapentaenoic acid | Eicosanoids [FA03] | - | 334.21 | C20H30O4 |
| LMFA03140011 | Resolvin E2 | 5S,18R-dihydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | - | 334.21 | C20H30O4 |
| LMFA03140013 | Resolvin E4 | 5S,15S-dihydroxy-6E,8Z,11Z,13E,17Z-eicosapentaenoic acid | Eicosanoids [FA03] | - | 334.21 | C20H30O4 |
| LMFA04000095 | Cymatherol C | 9-[(1R,2S,3S,5S)-3-[(1S,2R)-2-[(1R)-1-Hydroxypropyl]cyclopropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]nona-5Z,8Z-dienoic acid | Docosanoids [FA04] | - | 334.21 | C20H30O4 |
| LMFA04000105 | Ectocarpin C | (5Z,8Z,11Z)-12-{(1'R,2'S,3'S,5'S)-3-[(1''E)-1''-hydroxypropyl]-6'-oxabicyclo[3.1.0]hex-2'-yl}-5,8,11-dodecatrienoic acid | Docosanoids [FA04] | - | 334.21 | C20H30O4 |
Download LMSD record summary for FA 20:5;O2